Levine Childrens Hospital

Charlotte, North Carolina 28232

10 studies enrolling now · 59 studies all time

What they study most

ALL, Childhood, Acute Kidney Injury, Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia (ALL), Acute Lymphoblastic Leukemia/Lymphoma, Acute Myelogenous Leukemia, Acute Myelogenous Leukemia (AML or ANLL), Adenovirus, Adenovirus Infection, Arthritis, Juvenile Idiopathic, Autoimmune Diseases, B-cell Acute Lymphoblastic Leukemia

Studies at this site

• LCI-PED-NOS-EXER-001: Exercise in Pediatric Oncology Patients — Recruiting now
• Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA). — Recruiting now
• A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) — Recruiting now
• PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy — Recruiting now
• Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma — Recruiting now
• The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial — Recruiting now
• Pediatric Precision Laboratory Advanced Neuroblastoma Therapy — Recruiting now
• DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma — Recruiting now
• Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease — Recruiting now
• Beat Childhood Cancer Specimen Banking and Data Registry — Recruiting now
• Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center — Recruiting now
• Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL — Recruiting now
• Conditioning SCID Infants Diagnosed Early — Running, not enrolling
• A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202) — Running, not enrolling
• Haploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMTCTN1507) — Completed
• Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma — Running, not enrolling
• Neuroblastoma Maintenance Therapy Trial — Running, not enrolling
• Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis — Running, not enrolling
• EXCOR Active Driving System for the EXCOR Pediatric VAD IDE Study — Enrolling by invitation
• Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial) — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome — Running, not enrolling
• Molecular-Guided Therapy for Childhood Cancer — Completed
• Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy — Completed
• Epigenetic Reprogramming in Relapse/Refractory AML — Completed
• A Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AeroFact — Completed
• Apixaban for the Acute Treatment of Venous Thromboembolism in Children — Completed
• Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma — Stopped early
• Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma — Completed
• TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma — Completed
• Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide — Completed
• Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma — Completed
• Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma — Stopped early
• Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer — Completed
• Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in Remission — Completed
• Trial of Tolcapone With Oxaliplatin for Neuroblastoma — Stopped early
• Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy — Completed
• Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies — Status unconfirmed
• Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute Leukemia — Completed
• Treatment for Advanced B-Cell Lymphoma — Completed
• Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease — Completed
• Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease — NO_LONGER_AVAILABLE
• Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia — Completed
• Pediatric Acute Kidney Injury in COVID-19 — Completed
• Study to Assess the Safety and Efficacy of Brincidofovir in Treatment of Early Versus Late Adenovirus Infection — Completed
• Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD) — Completed
• Start Time Optimization of Biologics in Polyarticular JIA — Completed
• FIRSTx - A Study of Oral CXA-10 in Primary Focal Segmental Glomerulosclerosis (FSGS) — Completed
• Parent Educational Discharge Support Strategies — Completed
• A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in Children With Cancer — Completed
• Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy — Completed